Another brokerage firm, Edelweiss, has also maintained its buy rating on Nykaa but has trimmed its target price to Rs 1,743 from Rs 1,859 earlier, baking in a higher cost of capital and stiff competition as the key risks for the valuations.
Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash Devalkar
Indian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical and inflation challenges better than expected, with a